JANUS HENDERSON GROUP PLC - 31 Dec 2024 SCHEDULE 13G/A Report for AVADEL PHARMACEUTICALS PLC Common Stock (AVDL)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
AVADEL PHARMACEUTICALS PLC Common Stock
Symbol
AVDL
Shares outstanding
96,439,856 shares
Disclosed Ownership
14,080,219 shares
Ownership
14.6%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 11:55:04 UTC
Date of event
31 Dec 2024
Next filing
14 May 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 14.6% 14,080,219 0 14,080,219 Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 5.4% 5,203,295 0 5,203,295 Kristin Mariani Head of North America Compliance, CCO